EIRL vs. ARKG ETF Comparison

Comparison of iShares MSCI Ireland Capped ETF (EIRL) to ARK Genomic Revolution Multi-Sector ETF (ARKG)
EIRL

iShares MSCI Ireland Capped ETF

EIRL Description

The investment seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI Ireland Investable Market 25/50 Index (the "underlying index"). The fund generally invests at least 80% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index is a free float-adjusted market capitalization-weighted index designed to measure the performance of equity securities listed on stock exchanges in Ireland. Components primarily include consumer staples, industrials and materials companies. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$59.78

Average Daily Volume

18,900

Number of Holdings *

2

* may have additional holdings in another (foreign) market
ARKG

ARK Genomic Revolution Multi-Sector ETF

ARKG Description Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business. The companies held in ARKG may develop, produce or enable: CRISPR Targeted Therapeutics Bioinformatics Molecular Diagnostics Stem Cells Agricultural Biology ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry. ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution.

Grade (RS Rating)

Last Trade

$23.83

Average Daily Volume

2,221,130

Number of Holdings *

34

* may have additional holdings in another (foreign) market
Performance
Period EIRL ARKG
30 Days -10.04% 1.19%
60 Days -13.12% -6.00%
90 Days -13.99% -11.64%
12 Months 7.24% -13.66%
0 Overlapping Holdings
Symbol Grade Weight in EIRL Weight in ARKG Overlap
EIRL Overweight 2 Positions Relative to ARKG
Symbol Grade Weight
ICLR D 15.68%
AMBP D 2.36%
EIRL Underweight 34 Positions Relative to ARKG
Symbol Grade Weight
TWST D -8.37%
RXRX F -7.42%
CRSP D -7.34%
ADPT C -5.03%
CDNA D -4.77%
VCYT B -4.51%
SDGR C -4.14%
BEAM D -4.01%
NTLA F -3.89%
IONS F -3.85%
NTRA B -3.82%
NRIX D -3.78%
TXG F -3.56%
GH B -3.49%
ARCT F -3.19%
PSNL D -2.7%
ABSI F -2.19%
PACB F -2.16%
BFLY B -1.71%
VEEV C -1.7%
AMGN D -1.68%
ACCD D -1.47%
VRTX F -1.29%
ILMN D -1.25%
CERS C -1.18%
INCY C -1.11%
REGN F -0.92%
PRME F -0.9%
CMPS F -0.75%
MASS F -0.69%
QSI C -0.68%
EXAS D -0.65%
RPTX F -0.64%
MRNA F -0.01%
Compare ETFs